Lecendreux, ML, Dittmann, RW, Gasior, M, Banaschewski, T, Civil, R, Bloomfield, R, Squires, L, Coghill, DR.
Psychiatric-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: A phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe.
Neuropsychiatrie de l Enfance et de l Adolescence
60(5)
:
s263
2012
view publication
Banaschewski, T, Johnson, M, Zuddas, A, Soutullo, C, Hodgkins, P, Bloomfield, R, Squires, LA, Coghill, DR.
Health-related quality of life outcomes in children and adolescents with ADHD treated with lisdexamfetamine dimesylate.
Neuropsychiatrie de l Enfance et de l Adolescence
60(5)
:
s77
2012
view publication
Zuddas, A, Coghill, DR, Banaschewski, T, Soutullo, C, Lynes, A, Hodgkins, P, Gasior, M.
Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with ADHD: Post-hoc analysis from a phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe.
Neuropsychiatrie de l Enfance et de l Adolescence
60(5)
:
s263
2012
view publication
Coghill, D, Sonuga‐Barke, EJS.
Annual Research Review: Categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders – implications of recent empirical study.
Journal of Child Psychology and Psychiatry
53(5)
:
469 -489
2012
view publication
Rhodes, SM, Park, J, Seth, S, Coghill, DR.
A comprehensive investigation of memory impairment in attention deficit hyperactivity disorder and oppositional defiant disorder.
Journal of Child Psychology and Psychiatry
53(2)
:
128 -137
2012
view publication
